Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 13 | $9,546,610 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Feb 2024 17:59 | AXNX | Axonics Inc | NOBLETT KAREN | Chief Medical Officer | 31 Jan 2024 | Sale | 11,288 | 67.7359 | 764,603 | D |
02 Feb 2024 17:59 | AXNX | Axonics Inc | WOOCK JOHN | EVP, Chief Mktg/Strtgy Officer | 31 Jan 2024 | Sale | 15,899 | 67.7359 | 1,076,933 | D |
02 Feb 2024 17:59 | AXNX | Axonics Inc | FORD ALFRED J JR | Chief Commercial Officer | 31 Jan 2024 | Sale | 16,615 | 67.7359 | 1,125,432 | D |
02 Feb 2024 17:59 | AXNX | Axonics Inc | KEESE KARI LEIGH | Chief Financial Officer | 31 Jan 2024 | Sale | 3,489 | 67.7359 | 236,331 | D |
02 Feb 2024 17:59 | AXNX | Axonics Inc | COHEN RAYMOND W | Chief Executive Officer | 31 Jan 2024 | Sale | 35,161 | 67.7359 | 2,381,662 | D |
10 Jan 2024 20:00 | AXNX | Axonics Inc | NOBLETT KAREN | Chief Medical Officer | 08 Jan 2024 | Sale | 15,999 | 69.0019 | 1,103,961 | D |
28 Dec 2023 19:17 | AXNX | Axonics Inc | NOBLETT KAREN | Chief Medical Officer | 26 Dec 2023 | Sale | 949 | 63 | 59,787 | D |
28 Dec 2023 19:17 | AXNX | Axonics Inc | NOBLETT KAREN | Chief Medical Officer | 28 Dec 2023 | Sale | 7,051 | 63.2785 | 446,177 | D |
03 Oct 2023 19:37 | AXNX | Axonics Inc | DEAREN DANNY L. | President & CFO | 29 Sep 2023 | Sale | 7,675 | 56.8717 | 436,490 | D |
03 Oct 2023 19:32 | AXNX | Axonics Inc | DEAREN DANNY L. | President & CFO | 03 Feb 2022 | Sale A | 947 | 49.0347 | 46,436 | D |
03 Oct 2023 19:32 | AXNX | Axonics Inc | DEAREN DANNY L. | President & CFO | 03 Feb 2022 | Sale A | 17,737 | 48.2103 | 855,106 | D |
17 Aug 2023 19:47 | AXNX | Axonics Inc | FORD ALFRED J JR | Chief Commercial Officer | 15 Aug 2023 | Sale | 14,769 | 62.3381 | 920,671 | D |
01 Aug 2023 20:01 | AXNX | Axonics Inc | FORD ALFRED J JR | Chief Commercial Officer | 28 Jul 2023 | Sale | 1,500 | 62.014 | 93,021 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)